Federal Circuit Agrees Treatment Method Patent Is Invalid As Obvious
WASHINGTON, D.C. — A New Jersey federal judge properly deemed a patented method of treating diarrhea-predominant irritable bowel syndrome (IBS-D) with the drug Lotronex invalid, the Federal Circuit U.S. Court of...To view the full article, register now.
Already a subscriber? Click here to view full article